3471 - 3480 of 8471 Results
Title
Year
- DUOGLOBE: One‐Year Outcomes in a Real‐World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's Disease2021OPENTitle: DUOGLOBE: One‐Year Outcomes in a Real‐World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 7Start Page: 1061End Page: 1074Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13239Best OA location URL: http://europepmc.org/pmc/articles/PMC8485588Citation Count: 33
-
RESTRICTEDTitle: The Impact of Cloud Management Platforms on Nonprofit Business ModelsJournal Name: Journal of Technology in Human ServicesPublisher: Informa UK LimitedVol: 39Issue #: 4Start Page: 405End Page: 425Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/15228835.2021.1920556Citation Count: 5
- Cognition-Related Functional Topographies in Parkinson’s Disease: Localized Loss of the Ventral Default Mode Network2021OPENTitle: Cognition-Related Functional Topographies in Parkinson’s Disease: Localized Loss of the Ventral Default Mode NetworkJournal Name: Cerebral CortexPublisher: Oxford University Press (OUP)Vol: 31Issue #: 11Start Page: 5139End Page: 5150Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/cercor/bhab148Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491681Citation Count: 26
- Cognitive Impairment in Parkinson’s Disease: Epidemiology, Clinical Profile, Protective and Risk Factors2021RESTRICTEDTitle: Cognitive Impairment in Parkinson’s Disease: Epidemiology, Clinical Profile, Protective and Risk FactorsJournal Name: Behavioral SciencesPublisher: MDPI AGVol: 11Issue #: 5Start Page: 74End Page: 74Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/bs11050074Best OA location URL: https://www.mdpi.com/2076-328X/11/5/74/pdf?version=1621308905Citation Count: 45
- Decrease in Skin Prion-Seeding Activity of Prion-Infected Mice Treated with a Compound Against Human and Animal Prions: a First Possible Biomarker for Prion Therapeutics2021OPENTitle: Decrease in Skin Prion-Seeding Activity of Prion-Infected Mice Treated with a Compound Against Human and Animal Prions: a First Possible Biomarker for Prion TherapeuticsJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 58Issue #: 9Start Page: 4280End Page: 4292Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12035-021-02418-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s12035-021-02418-6.pdfCitation Count: 15
- Longitudinal Change in Quality of Life in Neurological Disorders Measures Over 3 Years in Patients with Early Parkinson's Disease2021OPENTitle: Longitudinal Change in Quality of Life in Neurological Disorders Measures Over 3 Years in Patients with Early Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1979End Page: 1983Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28641Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28641Citation Count: 3
-
OPENTitle: Longitudinal CSF proteomics identifies NPTX2 as a prognostic biomarker of Alzheimer's diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: 12Start Page: 1976End Page: 1987Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12353Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12353Citation Count: 81
- Posterior Cortical Cognitive Deficits Are Associated With Structural Brain Alterations in Mild Cognitive Impairment in Parkinson’s Disease2021OPENTitle: Posterior Cortical Cognitive Deficits Are Associated With Structural Brain Alterations in Mild Cognitive Impairment in Parkinson’s DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.668559Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2021.668559/pdfCitation Count: 24
- Subcortical microstructural diffusion changes correlate with gait impairment in Parkinson's disease2021RESTRICTEDTitle: Subcortical microstructural diffusion changes correlate with gait impairment in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 87Issue #:Start Page: 111End Page: 118Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.05.005Citation Count: 13
- Cerebrospinal α‐Synuclein Oligomers Reflect Disease Motor Severity in DeNoPa Longitudinal Cohort2021OPENTitle: Cerebrospinal α‐Synuclein Oligomers Reflect Disease Motor Severity in DeNoPa Longitudinal CohortJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 9Start Page: 2048End Page: 2056Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28611Best OA location URL: https://figshare.com/articles/journal_contribution/Cerebrospinal_Synuclein_Oligomers_Reflect_Disease_Motor_Severity_in__DeNoPa__Longitudinal_Cohort/22258267/2/files/39559891.pdfCitation Count: 32